All You Need to Know About Vivos Therapeutics Rating Upgrade to Buy
| VVOS Stock | USD 4.98 0.32 6.87% |
Slightly above 72 percent of all Vivos Therapeutics' private investors are curious in acquiring. The analysis of overall sentiment of trading Vivos Therapeutics stock suggests that a large number of investors are confidant at this time. Vivos Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Vivos Therapeutics' earnings reports, geopolitical events, and overall market trends.
Vivos |
Vivos Therapeutics has been upgraded to a Zacks Rank 2 , reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Read at zacks.com
 |
Vivos Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vivos Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vivos Therapeutics Fundamental Analysis
We analyze Vivos Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Vivos Therapeutics is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Vivos Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vivos Therapeutics stock to make a market-neutral strategy. Peer analysis of Vivos Therapeutics could also be used in its relative valuation, which is a method of valuing Vivos Therapeutics by comparing valuation metrics with similar companies.
Peers
Vivos Therapeutics Related Equities
| OM | Outset Medical | 9.01 | ||||
| DOCS | Doximity | 4.80 | ||||
| GH | Guardant Health | 1.73 | ||||
| DH | Definitive Healthcare | 0.97 | ||||
| LH | Laboratory | 0.72 | ||||
| VEEV | Veeva Systems | 0.00 | ||||
| CI | Cigna Corp | 0.00 | ||||
| MD | Mednax | 1.12 |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.